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SUMMARY. Drug resistance is a major obstacle for successful treatment of leukemia. Increasing evidence
suggests that microRNA-21 (miR-21) is over-expressed in K562/A02 cell line, promoting drug resistance.
The aim of our present study is to investigate the reversal effects of triptolide on drug resistance in adri-
amycin-resistant cells. Cell viability was measured by MTT assays and adriamycin induced apoptosis was
evaluated by flow cytometry. Levels of miR-21 quantified by real-time PCR. Bcl-2 protein level were mea-
sured by western blot. TPL enhanced sensitivity of K562/A02 cells to adriamycin and promoted adri-
amycin–induced apoptosis. Levels of miR-21 and Bcl-2 was significantly decreased after triptolide treat-
ment. Transfection with anti-miR-21, a significant up-regulation of sensitivity to adriamycin and a signifi-
cant down-regulation of Bcl-2 protein level was noted in K562/A02 cells. Our study suggests that triptolide
significantly sensitizes K562/A02 cell to adriamycin by inducing apoptosis and these effects of triptolide
may be due to its down-regulation of miR-21. 
